| 000 | 01908 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514223629.0 | ||
| 264 | 0 | _c20050822 | |
| 008 | 200508s 0 0 eng d | ||
| 022 | _a0951-3590 | ||
| 024 | 7 |
_a10.1080/09513590400021029 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMizutani, T | |
| 245 | 0 | 0 |
_aEffect of steroid add-back therapy on the proliferative activity of uterine leiomyoma cells under gonadotropin-releasing hormone agonist therapy. _h[electronic resource] |
| 260 |
_bGynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology _cFeb 2005 |
||
| 300 |
_a80-3 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xadministration & dosage |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aEstrogens, Conjugated (USP) _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGonadotropin-Releasing Hormone _xagonists |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHysterectomy |
| 650 | 0 | 4 |
_aLeiomyoma _xpathology |
| 650 | 0 | 4 |
_aLeuprolide _xadministration & dosage |
| 650 | 0 | 4 |
_aMedroxyprogesterone Acetate _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xpathology |
| 650 | 0 | 4 | _aPostoperative Period |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aUterine Neoplasms _xpathology |
| 700 | 1 | _aSugihara, A | |
| 700 | 1 | _aHonma, H | |
| 700 | 1 | _aKomura, H | |
| 700 | 1 | _aNakamuro, K | |
| 700 | 1 | _aTerada, N | |
| 773 | 0 |
_tGynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology _gvol. 20 _gno. 2 _gp. 80-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/09513590400021029 _zAvailable from publisher's website |
| 999 |
_c15492775 _d15492775 |
||